Immunon, Inc. R&D discussion in New York City to test the potential of IL-12 to treat ovarian cancer The program includes leading experts in the field of ovarian cancer, researchers from the OVATION 2 study, and oncology experts. LAWRENCEVILLE, NJ, Aug. 28, 2024 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a late-stage clinical-stage company with […]